Zosano Pharma Corporation (NASDAQ:ZSAN) ended Tuesday’s trading session in green, attempting to recover from the recent sell-off. The stock has corrected almost 40% from February’s peak price.
Zosano Appoints Industry Veteran, Kathy McGee, to its Board of Directors
- ZSAN announced the appointment of Kathy McGee, an accomplished biopharmaceutical executive, to its board of directors. Ms. McGee brings experience from a broad range of leadership roles across operations, strategic planning, manufacturing and supply chain management, quality and regulatory affairs and new product development.
- Ms. McGee is currently chief operating officer of AVITA MEDICAL, where she is responsible for manufacturing operations, facilities and engineering, supply chain, program management, new product development, information technology and quality and regulatory affairs.
- Prior to AVITA, she was president of CnA Consulting Group, a life science consulting firm specializing in helping companies with strategic planning and analysis, mergers and acquisitions strategy, chemistry, manufacturing and controls planning, pre-approval readiness, technical operations and supply chain logistics, compliance and regulatory management.
- Earlier in her career, she served in executive roles at Shire Regenerative Medicine, where she led West Coast Operations and Advanced Biohealing, Inc. where she was a general manager of the organization. Ms. McGee has a Master of Arts degree from Webster University, St. Louis and a Bachelor of Science in Chemistry and Mathematics from University College, Galway.
“Kathy is an exceptional addition to the board, bringing deep experience across many functional areas, and we are thrilled to have her join our board,” said Steven Lo, president and chief executive officer of Zosano.
On Tuesday, ZSAN stock went up 2.22% to close at $0.7462. Total volume stood at over 920K shares traded hands for the session, compared to its 30-day average volume of 2.75 million shares. The stock moved in a narrow range of $0.7211 – 0.7499 for the session.